IL-5 priming of eosinophil function in asthma

Clinical and Experimental Allergy

Volumn 31, Issue 4, 2001, Pages 513-517

  Sampson, A P ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 2 [1 (3 DIMETHYLAMINOPROPYL) 5 METHOXY 1H INDOL 3 YL] 3 (1H INDOL 3 YL)MALEIMIDE; ALLERGEN; BETA1 INTEGRIN; CD11 ANTIGEN; CD18 ANTIGEN; CELL ADHESION MOLECULE; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; MAJOR BASIC PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE C INHIBITOR; RANTES; STAUROSPORINE; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; WORTMANNIN;

AEROBIC METABOLISM; ASTHMA; BRONCHOSPASM; BRONCHUS BIOPSY; BRONCHUS HYPERREACTIVITY; CELL ACTIVATION; CELL ADHESION; CELL COUNT; CELL DENSITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSPORT; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG EFFECT; EDITORIAL; ENZYME ACTIVATION; ENZYME INHIBITION; EOSINOPHIL; FORCED EXPIRATORY VOLUME; HOUSE DUST ALLERGY; HUMAN; IMMUNOMODULATION; LOEFFLER PNEUMONIA; LUNG EXTRAVASCULAR FLUID; LUNG LAVAGE; NONHUMAN; PATHOPHYSIOLOGY; POLLEN ALLERGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION;

ASTHMA; EOSINOPHILS; HUMANS; INTERLEUKIN-5;

EID: 0035726430     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2001.01046.x     Document Type: Editorial

References (27)

1. Eosinophils and asthma: What do measurements tell us?
2. Mechanisms of eosinophil-associated inflammation
3. Allergic networks regulating eosinophilia
4. Effect of inhaled interleukin5 on airway hyperreactivity and eosinophilia in asthmatics
5. Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma
6. 4 secretion by integrinmediated endothelial cell adhesion
7. Human eosinophils
8. CD4 T-lympbocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5
9. IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity
10. Migration of primed human eosinophils across cytokine-activated endothelial cell monolayers
11. Characteristics of airway eosinophils
12. Upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma
13. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects
14. Secretion of granule proteins from eosinophils and neutrophils is increased in asthma
15. Granulocyte-macrophage colony-stimulating factor, interleulcin-3 (IL-3), and IL-5 greatly enhance the interaction of human eosinophils with sonized particles by changing the affinity of complement receptor type 3
16. IL-5 priming of the PMA-ioduecd oxidative metabolism of human eosinophils from allergic and normal subjects during a pollen season
17. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure
18. Seasonal allergen exposure increases expression of leukotriene pathway enzymes and induces eosinophil influx in bronchial mucosa of atopic asthmatics
19. Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: Effect of immunotherapy
20. The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung
21. Identification of IL5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung
22. Oxygen radical production by blood eosinophils is reduced during birch pollen season in allergic patients
23. Lack of increased numbers of low-density eosinophils in the circulation of asthmatic individuals
24. Eosinophil priming by cytokines: From cellular signal to in vivo modulation
25. 4 synthesis
26. Lyn, Jak2, and Raf-1 kinases are critical for the antiapoptotic effect of interleukin-5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation
27. SB240563, a humanized anti-IL-5 monoclonal antibody: Initial single-dose safety and activity in patients with asthma